Granite Bio raised a $30m Series A round co-led by Versant Ventures and Novartis Venture Fund

Biotech Health services Manufacturing

Switzerland

United States

Investments

24 December 2023

Share:

Granite Bio (company)

Switzerland

Biotech Health services Manufacturing

Total investments received (USD): 100m

Round value (USD): 30m

Round investors: Novartis Venture Fund Versant Ventures

Company: Granite Bio

Industry: Biotech Health services Manufacturing

Related deals

Memo Therapeutics raised CHF 20 million in Series C extension funding from investors including Ysios Capital and Kurma Partners.

Biotech Health services Manufacturing

Switzerland

France

Spain

Investments 01 May 2024

LEM Surgical raised €23.6 million series B

Health services Manufacturing Robotics

Switzerland

Investments 24 December 2023

Vandria in a CHF18 million series A round led by ND Capital together with a small syndicate of HNW private investors.

Biotech Health services Manufacturing Pharma

Switzerland

United States

Investments 15 December 2023

Mootral raised $20 million led by King Philanthropies, joined by Lowercarbon Capital, Kindred Ventures, Third Derivative, and Climate Capital.

Agriculture Biotech Energy Manufacturing Social Responsibility

Switzerland

United States

Investments 06 December 2023

Memo Therapeutics in a €26 million Series C led by Pureos Bioventures, with Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders

Biotech Health services Manufacturing

Switzerland

United States

United Kingdom

Luxembourg

Germany

Investments 30 October 2023